Free shipping from €49. Free gift from €59.

Guides

HAIR LOSS

What can weaken minoxidil, and how to use it safely

2 min read6 steps9 studies

In short

Minoxidil needs a scalp enzyme to work, and aspirin lowered it in a small study. The best-proven hair-loss options are minoxidil and anti-DHT drugs such as finasteride.

Scalp Applicator in use

What you need

Do this

  1. 1

    Minoxidil must be switched on by the enzyme SULT1A1 in your follicles.

  2. 2
    Daily low-dose aspirin lowered predicted response.Why

    Ask a doctor before changing any aspirin.

  3. 3
    Tretinoin raised the enzyme in a small study.Why

    Talk to a doctor first.

  4. 4

    What the science points to: similar pain pills may too (possible).

  5. 5

    Keep cats away from the product, your wet scalp and your pillowcase.

  6. 6
    Itchy scalp? Foam has no propylene glycol.Why

    A patch test tells allergy from irritation.

The numbers behind it

  • 50% to 27%

    Share of 24 people predicted to respond to minoxidil before and after 14 days of daily low-dose aspirin. Hair growth was not measured.

  • 43%

    Of people predicted not to respond to minoxidil were predicted to respond after 5 days of topical tretinoin.

  • 75% vs 33%

    Regrew hair with 5% minoxidil plus an enzyme booster versus a sham booster after 60 days (24 men).

  • 8 of 62

    Cats with signs after exposure to an owner's minoxidil died (211 dog and cat cases from a poison centre).

For your hair

  • Pain pills (liver-tissue data)

    Mefenamic acid and salicylic acid blocked the same enzyme in human liver tissue. What the science points to: a weaker minoxidil effect is possible.

  • Curcumin and quercetin tablets (lab-tissue data)

    Both block the enzyme in lab tissue. What the science points to: tablets may not reach follicles, so a weaker effect is less likely.

  • Cat and dog owners

    Cats were mostly exposed by licking an owner's skin or pillowcase. Wash your hands after applying and let it dry before bed.

  • Daily aspirin users

    Aspirin is usually taken for the heart. Never stop it on your own. Talk to a doctor about whether this matters.

Myths to ignore

  • Myth Itch from minoxidil is always the propylene glycol in the liquid.

    Truth In 99 patch-test-confirmed allergy cases, minoxidil itself was the allergen 4 times as often as propylene glycol. A patch test separates allergy from irritation.

    Kiratiwongwan 2025 ↗
  • Myth Itchy and red after minoxidil always means allergy.

    Truth Irritation looks the same as allergy. People sensitive to propylene glycol can be offered other formulations such as foam.

    Junge 2025 ↗
  • Myth A few drops on a pet are harmless.

    Truth Signs followed even drops or licks.

    Tater 2021 ↗

Go deeper

All studies in this guide (9)

Goren A et al. Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. Dermatol Ther. 2018

Design
cohort
People
24
Duration
14 days
Who
people with androgenetic alopecia

Tested: low-dose oral aspirin (75-81 mg/day) with hair follicle sulfotransferase enzyme activity measured before and after

Result: Half of the 24 people (50%) were predicted to respond to topical minoxidil at the start. After 14 days of low-dose aspirin only 27% were. Hair growth itself was not measured.

Read the study ↗

Sharma A et al. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatol Ther. 2019

Who
small cohort with predicted minoxidil non-response

Tested: topical tretinoin for 5 days

Result: Tretinoin raised follicular sulfotransferase and 43% of predicted non-responders were converted; the group is tied to a commercial response test.

Read the study ↗

Dhurat R et al. SULT1A1 (minoxidil sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth. J Cosmet Dermatol. 2022

Design
rct
People
24
Duration
60 days
Who
men with androgenetic alopecia (Norwood 2 to 6)

Tested: 5% minoxidil daily plus a topical enzyme booster versus plus a sham booster

Result: 75% of men using the booster regrew hair versus 33% using the sham (12 per group, judged on global photos).

Read the study ↗

Pacifici GM. Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. Int J Clin Pharmacol Ther. 2004

Design
review
Who
human liver and duodenum tissue studies

Tested: mefenamic acid, salicylic acid and quercetin tested against sulfotransferase activity

Result: Mefenamic acid, salicylic acid and quercetin all blocked the enzyme SULT1A1 in human liver tissue, and quercetin blocked the sulfation of minoxidil. Nothing was tested in hair follicles.

Read the study ↗

Vietri M et al. Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues. Xenobiotica. 2003

Who
50 human liver samples and five samples each of duodenum, colon, kidney and lung

Tested: curcumin added to tissue samples

Result: Curcumin blocked SULT1A1 strongly in every tissue at nanomolar levels, far below the level reached in blood after a 4 g dose. Hair follicles were not tested.

Read the study ↗

Tater KC et al. Topical minoxidil exposures and toxicoses in dogs and cats: 211 cases (2001-2019). J Am Anim Hosp Assoc. 2021

Design
case series
People
211
Who
dogs and cats reported to a poison centre

Tested: accidental exposure to topical minoxidil

Result: Signs followed even a few drops or licks; 8 of 62 symptomatic cats died.

Read the study ↗

Kiratiwongwan R et al. Allergic contact dermatitis to topical preparations containing minoxidil: a systematic review and individual participant data meta-analysis. Dermatitis. 2025

Design
systematic review
People
99
Who
99 people with allergic contact dermatitis to topical minoxidil, confirmed by patch test (46 studies)

Result: Minoxidil itself was the allergen in 74.7% and propylene glycol in 17.1%.

Read the study ↗

Junge A et al. Contact dermatitis caused by topical minoxidil: allergy or just irritation. Acta Derm Venereol. 2025

Design
systematic review
Who
21 studies of contact dermatitis from topical minoxidil

Result: Among patch-test-positive people, 54 reacted to minoxidil itself and 12 to the other ingredients in the product. Redness, itch and scaling after use need a patch test to tell allergy from irritation, and people sensitive to propylene glycol can be offered other formulations.

Read the study ↗

Olsen EA et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007

Design
rct
People
352
Duration
16 weeks
Who
men with androgenetic alopecia

Tested: 5% minoxidil foam (propylene-glycol-free) vs placebo

Result: Hair counts rose significantly more than with placebo (P<0.0001) and the foam was well tolerated for up to 52 weeks.

Read the study ↗